Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8
Interventions: Biospecimen Collection, Computed Tomography, Fluorouracil, Irinotecan, Ivonescimab, Leucovorin Calcium, Magnetic Resonance Imaging, Muzastotug; Procedure · Drug · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Type 2 Diabetes
Interventions: Biophoton Generators; Device
Lead sponsor: First Institute of All Medicines; Other
Eligibility: 18 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Tampa, Florida • Butler, Pennsylvania

Conditions: Atrial Fibrillation (AF), Mitral Valve (MV) Regurgitation
Interventions: Left Atrial Appendage Occlusion, Mitral Valve Transcatheter Edge to Edge Repair; Device
Lead sponsor: EchoPixel, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Opioid Use Disorder, Tobacco Use Disorder
Interventions: Deep TMS System With H4 Coil; Device
Lead sponsor: Payel Roy; Other
Eligibility: 22 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Pediatric, Coagulation
Interventions: Quantra System; Diagnostic Test
Lead sponsor: HemoSonics LLC; Industry
Eligibility: Up to 17 Years
Enrollment: 240 participants
Timeline: 2027 – 2028
U.S. locations: 3
States / cities: Los Angeles, California • Atlanta, Georgia • Boston, Massachusetts

Conditions: Alzheimer's Dementia (AD)
Interventions: buntanetap/posiphen; Drug
Lead sponsor: Annovis Bio Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 14
States / cities: Englewood, Colorado • Daytona Beach, Florida • Maitland, Florida + 11 more

Conditions: Widspread Chronic Pain, Fibromyalgia
Interventions: Vagal nerve stimulation through deep exhalation exercise, Vagal nerve stimulation through ear electrical stimulation, No intervention (observational study); Other
Lead sponsor: University of North Georgia; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dahlonega, Georgia

Conditions: Psychological Distress, Psychological Well-being
Interventions: Core Transformation Process; Behavioral
Lead sponsor: Andreas NLP (Legal Entity - Real People Press); Other
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Hemorrhoids Internal, Hemorrhoids Second Degree, Hemorrhoids Third Degree
Interventions: Rectal Artery Embolization, Operative Hemorrhoidectomy; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Neuroendocrine (NE) Tumors, Advanced NET of GI Origin
Interventions: AUR103 Calcium; Drug
Lead sponsor: Aurigene Discovery Technologies Limited; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 5
States / cities: Phoenix, Arizona • Newport Beach, California • Jacksonville, Florida + 2 more

Conditions: Actinic Keratoses
Interventions: Combination field therapy with 5-fluorouracil and calcipotriene (5FU/C); Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Cleveland, Ohio

Conditions: Sensory Processing Disorder
Interventions: Not listed
Lead sponsor: Life University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Chippewa Falls, Wisconsin

Conditions: Radiation Necrosis, Cerebral Edema
Interventions: Transcutaneous auricular vagal nerve stimulation (taVNS), Sham; Device
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Hip Dysplasia, Hip Pain Chronic, Hip Osteoarthritis, Hip Arthritis, Psychosocial Problem
Interventions: Cell Phone Based Cognitive Based Therapy (Pacifica App), Control; Device · Other
Lead sponsor: Michael C Willey; Other
Eligibility: 15 Years to 39 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Heart Failure, Coronary Artery Disease, Peripheral Artery Disease, Ischemia, Hypertension, Diabetes Mellitus, Cardiomyopathies, Cardiotoxicity
Interventions: Clinical Decision Aid, Standard Care; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Ascites, Liver Cirrhosis, Hypertension, Portal
Interventions: Proximal Splenic Artery Embolization; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: Hip Exoskeleton-Assisted Walking; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 45 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: JAK1 GOF, STAT1 GOF, STAT3 GOF, STAT5B GOF, STAT6 GOF
Interventions: Upadacitinib, Placebo; Drug
Lead sponsor: Lisa Satter; Other
Eligibility: 12 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: St Louis, Missouri • New York, New York • Houston, Texas

Conditions: PTSD - Post Traumatic Stress Disorder, Substance Use
Interventions: Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Healthy Volunteers
Interventions: Formulation A, Formulation B, Formulation C; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Primary Ciliary Dyskinesia, PCD
Interventions: Exercise, HS pretreatment with Exercise; Behavioral · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Traumatic Brain Injury, Traumatic Brain Injury (TBI) Patients, Traumatic Brain Injury (TBI); Concussion, Initial Encounter, Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter, Traumatic Brain Injury With Brief Loss of Consciousness, Traumatic Brain Injury With Persistent Cognitive Deficits
Interventions: MUSE Stem Cell Therapy; Biological
Lead sponsor: Healing Hope International; Other
Eligibility: 6 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2036
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Borderline Personality Disorder, Borderline Personality Pathology, Depressive Symptoms, Emotion Dysregulation, Suicidal Ideation
Interventions: Psilocybin, Psilocybin-Assisted Therapy With Dialectical Behavior Therapy; Drug · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Louis Park, Minnesota

Conditions: Moderate to Severe Insomnia
Interventions: Transcranial alternating current stimulator; Device
Lead sponsor: Nexalin Technology; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

RCT to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes

EPX-HTG for Structural Heart Procedures

Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder

Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients

An Open-label Long-term Safety Study of Buntanetap in Participants With AD

The Effect of Vagus Nerve Stimulation on Pain and Functional Activities in Individuals With Chronic Widespread Pain

Two Sessions of Coach-Delivered Core Transformation for Distress and Well-Being

Comparing Rectal Artery Embolization and Surgery for Treatment of Bleeding Grade 2 and 3 Internal Hemorrhoids

AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses

Chiropractic for Kids With Sensory Processing Challenges

TENS of Auricular Vagal Nerve for Radiation Necrosis

Psychosocial Interventions for Young Adults With Hip Pain

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis

Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD

Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

CBITS-RTM Pilot Study

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

Clearance in Primary Ciliary Dyskinesia

Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury

ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder

HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia